sickle cell

A young Mississippi woman is thriving two years after getting treated for sickle cell disease with the revolutionary gene-editing technique known as CRISPR.

Researchers at the University of Florida College of Nursing have been awarded a $2.6 million grant to determine whether relaxation therapy can help reduce…

Since receiving a landmark treatment with the gene-editing tool CRISPR, a sickle cell patient has the strength to care for herself and her children — while navigating the pandemic.

Victoria Gray, 34, of Forest, Miss., has sickle cell disease. She is the first patient ever to be publicly identified as being involved in a study testing the use of CRISPR for a genetic disease.

The number of babies born with the life-threatening disease will climb by a third in the next 40 years, scientists say. The vast majority of sickle cell cases will occur in developing countries, which don't have the resources to treat deadly complications arising from the genetic disorder.